AmbrogioLab retweeted
Pls RT: Are you studying the multifaceted MAPK pathway? We would love to hear about your exciting research!
Abstract Deadline 👉16.12.2024 for the #virtualmeeting on "Drugging and regulating the #MAPKpathway"
organised with @EACRnews with @Boehringer eacr.org/conference/boe…
Abstract Deadline 👉16.12.2024 for the #virtualmeeting on "Drugging and regulating the #MAPKpathway"
organised with @EACRnews with @Boehringer eacr.org/conference/boe…
Excited to co-organize the virtual @EACRnews @Boehringer Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an abstract or join us. Please RT and share with others.
Details & registration:
eacr.org/conference/boe…
0
13
22
5,350
AmbrogioLab retweeted
📖 🎯
A new book!
RAS Drug Discovery
•
Past, Present and Future
🔸️
A comprehensive overview of the state-of-the-art medicinal chemistry approaches towards targeting the formerly undruggable oncogene, KRAS.
@Aiims1742 @AndresFCardonaZ @FredNatLab @Tony_Calles @chulkimMD nVLiu @BenjaminBesseMD @EricTopol @gerlach_d @ArndtVogel @RonDePinho @DrYukselUrun @DavidHongMD @CadranelJ @pashtoonkasi @ChadPecot @JacobAdashek @AmbrogioLab 🔸️
shop.elsevier.com/books/ras-drug…
A new book!
RAS Drug Discovery
•
Past, Present and Future
🔸️
A comprehensive overview of the state-of-the-art medicinal chemistry approaches towards targeting the formerly undruggable oncogene, KRAS.
@Aiims1742 @AndresFCardonaZ @FredNatLab @Tony_Calles @chulkimMD nVLiu @BenjaminBesseMD @EricTopol @gerlach_d @ArndtVogel @RonDePinho @DrYukselUrun @DavidHongMD @CadranelJ @pashtoonkasi @ChadPecot @JacobAdashek @AmbrogioLab 🔸️
shop.elsevier.com/books/ras-drug…
0
10
41
3,959
AmbrogioLab retweeted
I am excited for the next three days of @theNCI's RAS Initiative Symposium 2024. Today, @NCIDirector Rathmell and AACR Past President Frank McCormick kicked off this important meeting aimed at mobilizing the cancer research community to target RAS-driven cancers.
1
9
49
3,410
AmbrogioLab retweeted
Excited to co-organize the virtual @EACRnews @Boehringer Conference: Drugging & Regulating the MAP Kinase Pathway! Submit an abstract or join us. Please RT and share with others.
Details & registration:
eacr.org/conference/boe…
Details & registration:
eacr.org/conference/boe…
0
20
47
12,011
Our latest publication online now! rdcu.be/dSvhN @NatureComms
Amazing team work @lab_santamaria @MJNokin @BiagioRicciutMD @DrMarkAwad @NadalErnest @cereda_lab
Amazing team work @lab_santamaria @MJNokin @BiagioRicciutMD @DrMarkAwad @NadalErnest @cereda_lab
0
6
35
1,622
AmbrogioLab retweeted
Happy to share our new publication on redox sensitivities of drug persistent and resistant BRAF mutated lung cancer. @GIGA_ULiege @iecb_bordeaux @ciccancer @lab_santamaria @AmbrogioLab @frsFNRS @televie @FondationLeon cell.com/cell-reports-m…
1
3
13
904
Our PREDICT project is among the 2024 ERC Proof of Concept grants! @ERC_Research #ERCPoC
📣 Out now! First results of the 2024 ERC Proof of Concept call.
100 grants – each worth €150,000 – will help ERC grantees to bridge the gap between the discoveries stemming from their frontier research and their practical application.
More 👉 europa.eu/!rWx4w3
4
4
36
2,693
AmbrogioLab retweeted
EACR-@Mark Foundation Postdoctoral Fellowships are awarded for a period of three years and support excellent postdoctoral researchers in laboratories throughout Europe. Is that you? 👀
Apply by 21 August: eacr.org/eacr-fellowshi…
Apply by 21 August: eacr.org/eacr-fellowshi…
0
5
10
1,884
AmbrogioLab retweeted
There are just a few more days left to register for our upcoming Early-Career Researchers' Conference, happening online 25-26 June!
👉 Don't miss the 12 June deadline: eacr.org/conference/ear…
👉 Don't miss the 12 June deadline: eacr.org/conference/ear…
1
14
22
4,570
AmbrogioLab retweeted
Stunning results from @CanaudLab who just presented their case study that led to an FDA-approved drug. Thanks @unito for organizing it! #research #24May
0
1
5
900
AmbrogioLab retweeted
There's not long left to wait until the EACR Congress comes to the Netherlands in June! ☀️
Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 29 April.
2024.eacr.org
Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 29 April.
2024.eacr.org
1
7
12
1,789
AmbrogioLab retweeted
Read the #CancerHallmarks Perspective—
Piecing the Puzzle Together.
bit.ly/3JnQwuv
@AmbrogioLab @MariaPAlcolea @gemmakelly_1 @waileongtam @theLundLab @alpcorreia @CJHPhD @IngunnStromnes @DanielaQuail @ErnstAurelie @DirenaAC @ShemaEfrat @BullmanLab @Marcus_Ruscetti
Piecing the Puzzle Together.
bit.ly/3JnQwuv
@AmbrogioLab @MariaPAlcolea @gemmakelly_1 @waileongtam @theLundLab @alpcorreia @CJHPhD @IngunnStromnes @DanielaQuail @ErnstAurelie @DirenaAC @ShemaEfrat @BullmanLab @Marcus_Ruscetti
2
15
32
7,077
AmbrogioLab retweeted
Can you believe we got to fund 9 LS1 @ERC_research grants?!?🤩HUGE congratulations to:@clausen_lab, @Archaellum,T. Hoppe @CECAD_ , @Tampe_Lab, Y. Senis @Inserm, M. Glickman @BiologyTechnion, M. Foiani @IFOMresearch, @photosyn_Adam & @hecklab! Amazing&very diverse set of projects!
📣 Good news today for 255 outstanding research leaders who have been offered ERC Advanced Grants.
The new funding, worth nearly €652 million, is part of the 🇪🇺EU’s #HorizonEurope programme.
Read more 👉 europa.eu/!TkwhWc
#ERCAdG #FrontierResearch @EUScienceInnov
1
3
29
4,842
AmbrogioLab retweeted
Just published with the #AACR24 presentation in Attacking #KRAS Beyond G12C:
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers, by Jingjing Jiang, Zhengping Wang, Mallika Singh et al.
bit.ly/3vNIQ1A
#RevolutionMedicines
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers, by Jingjing Jiang, Zhengping Wang, Mallika Singh et al.
bit.ly/3vNIQ1A
#RevolutionMedicines
0
20
40
18,218
AmbrogioLab retweeted
@BiagioRicciutMD from @DanaFarber is presenting today at #AACR2024 section 41 poster 18 new data on wild type KRAS amplification as a de novo oncogenic driver in NSCLC. Terrific work done in collaboration with @AmbrogioLab. @DrMarkAwad @KRASKickers
0
3
14
1,165
AmbrogioLab retweeted
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy | Nature #AACR24 nature.com/articles/s4158…
0
8
22
2,533
AmbrogioLab retweeted
Out in @Nature concurrent with #AACR24
Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on #PancreaticCancer
@KenOliveLab @BenStanger01 @derlabunc
nature.com/articles/s4158…
nature.com/articles/s4158…
Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on #PancreaticCancer
@KenOliveLab @BenStanger01 @derlabunc
nature.com/articles/s4158…
nature.com/articles/s4158…
1
78
230
64,711
@DirenaAC @CD_AACR @IRBBarcelona @MSKCancerCenter @LoweLabMSKCC @msmelanoma Congrats Direna!! 👏🏻👏🏻👏🏻
0
0
1
133